Merck Manual

Please confirm that you are a health care professional

Loading

Thin Basement Membrane Disease

(Benign Familial Hematuria)

By

Frank O'Brien

, MD, Washington University in St. Louis

Last full review/revision Jan 2020| Content last modified Jan 2020
Click here for Patient Education
Topic Resources

Thin basement membrane disease is diffuse thinning of the glomerular basement membrane from a width of 300 to 400 nm in normal subjects to 150 to 225 nm.

Thin basement membrane disease is a type of nephritic syndrome. It is hereditary and usually transmitted in autosomal dominant fashion. Not all genetic mutations have been characterized, but in some families with thin basement membrane disease there is a mutation in the type IV collagen alpha-4 gene. Prevalence is estimated to be 5 to 9%.

Symptoms and Signs

Most patients are asymptomatic and are incidentally noted to have microscopic hematuria on routine urinalysis, although mild proteinuria and gross hematuria are occasionally present. Renal function is typically normal, but a few patients develop progressive renal failure for unknown reasons. Recurrent flank pain, similar to that in immunoglobulin A nephropathy, is a rare manifestation.

Diagnosis

  • Clinical evaluation

  • Sometimes renal biopsy

Diagnosis is based on family history and findings of hematuria without other symptoms or pathology, particularly if asymptomatic family members also have hematuria. Renal biopsy is unnecessary but is often done as part of a hematuria evaluation. Early on, thin basement membrane disease may be difficult to differentiate from hereditary nephritis because of histologic similarities. Molecular genetic analysis can help differentiate these 2 diseases.

Treatment

  • For frequent gross hematuria, flank pain, or proteinuria, angiotensin-converting enzyme (ACE) inhibitors or angiotensin II receptor blockers (ARBs)

Long-term prognosis is excellent, and no treatment is necessary in most cases. Patients with frequent gross hematuria, flank pain, or proteinuria (eg, urine protein/creatinine ratio of > 0.2) may benefit from ACE inhibitors or ARBs, which may lower intraglomerular pressure.

Click here for Patient Education
NOTE: This is the Professional Version. CONSUMERS: Click here for the Consumer Version
Professionals also read

Also of Interest

Videos

View All
How To Do Urethral Catheterization in Males
Video
How To Do Urethral Catheterization in Males
3D Models
View All
Male Reproductive System
3D Model
Male Reproductive System

SOCIAL MEDIA

TOP